Patients with coronary, cerebrovascular or peripheral arterial obstructive disease differ in risk for new vascular events and mortality: the SMART study

被引:38
作者
Achterberg, Sefanja [1 ]
Cramer, Maarten J. M. [2 ]
Kappelle, L. Jaap [1 ]
de Borst, Gert Jan [3 ]
Visseren, Frank L. J. [4 ]
van der Graaf, Yolanda [5 ]
Algra, Ale [1 ,5 ]
机构
[1] Univ Med Ctr Utrecht, Dept Neurol, Rudolf Magnus Inst Neurosci, NL-3508 GA Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Cardiol, NL-3508 GA Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Dept Vasc Surg, NL-3508 GA Utrecht, Netherlands
[4] Univ Med Ctr Utrecht, Dept Vasc Med, NL-3508 GA Utrecht, Netherlands
[5] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands
来源
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION | 2010年 / 17卷 / 04期
关键词
ORAL ANTICOAGULANT-THERAPY; BLEEDING COMPLICATIONS; OUTPATIENTS; PREVENTION; PREVALENCE;
D O I
10.1097/HJR.0b013e3283361ce6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Atherosclerosis causes coronary artery disease (CAD), cerebrovascular disease (CVD) or peripheral arterial obstructive disease (PAOD). The risk of new vascular events and mortality is high. Direct comparisons of vascular event rates are scarce. Methods and results Vascular risk factors and outcome events of 3563 patients from a university hospital presenting with nondisabling CAD, CVD or PAOD were compared with regression analyses, adjusted for age and sex (median follow-up, 3.9 years). The primary outcome was the composite of myocardial infarction, stroke and vascular death. The risk among the three groups of outcomes was compared using the Cox regression analysis. At baseline, CAD patients were the most obese; PAOD patients smoked the most and suffered more often from hypertension and hyperlipidaemia. The average rate of vascular events was 2.5% per year; the hazard ratio (HR) of CVD/CAD was 1.7 [95% confidence interval (CI): 1.3-2.2] and PAOD/CAD was 1.8 (95% CI: 1.5-2.0). PAOD patients had a higher risk for coronary events than CAD (HR: 1.6; 95% CI: 1.2-2.1). Patients with CVD or PAOD had a higher risk for major bleeding than CAD patients (HR: 2.1; 95% CI: 1.4-3.2). Conclusion Patients with a recent CVD or PAOD have almost twice the risk for future vascular events than those with CAD. Eur J Cardiovasc Prev Rehabil 17: 424-430 (C) 2010 The European Society of Cardiology
引用
收藏
页码:424 / 430
页数:7
相关论文
共 23 条
[1]  
BAINTON D, 1994, BRIT HEART J, V72, P128
[2]   International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis [J].
Bhatt, DL ;
Steg, PG ;
Ohman, EM ;
Hirsch, AT ;
Ikeda, Y ;
Mas, JL ;
Goto, S ;
Liau, CS ;
Richard, AJ ;
Röther, J ;
Wilson, PWF ;
Andersen-Dalheim, H ;
Anderson, P ;
Anell, B ;
Arber, S ;
Armstrong, K ;
Arnot, D ;
Baldam, A ;
Barratt, I ;
Barresi, S ;
Beder, J ;
Benson, M ;
Bergman, F ;
Best, J ;
Bhasim, R ;
Bovell, G ;
Bowman, N ;
Brkic, M ;
Bromberger, D ;
Brown, D ;
Brown, J ;
Brownstein, M ;
Bruce, A ;
Buonopane, J ;
Burns, S ;
Butler, A ;
Byrne, D ;
Carson, J ;
Cassimatis, P ;
Chaffey, G ;
Chambers, D ;
Chan, WJ ;
Chan, B ;
Cheatham, J ;
Chen, R ;
Cheong, B ;
Cheung, C ;
Chin, J ;
Chiu, A ;
Choo, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (02) :180-189
[3]   Comparison of cardiovascular risk factors and drug use in 14 544 French patients with a history of myocardial infarction, ischaemic stroke and/or peripheral arterial disease [J].
Bongard, V ;
Cambou, JP ;
Leizorovicz, A ;
Fernères, J ;
Vahanian, A ;
Jullien, G ;
Coppe, G ;
Guerillot, M ;
Herrmann, MA ;
Mas, JL .
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2004, 11 (05) :394-402
[4]  
Casais P, 2000, AM J HEMATOL, V63, P192, DOI 10.1002/(SICI)1096-8652(200004)63:4<192::AID-AJH5>3.0.CO
[5]  
2-K
[6]   MORTALITY OVER A PERIOD OF 10 YEARS IN PATIENTS WITH PERIPHERAL ARTERIAL-DISEASE [J].
CRIQUI, MH ;
LANGER, RD ;
FRONEK, A ;
FEIGELSON, HS ;
KLAUBER, MR ;
MCCANN, TJ ;
BROWNER, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (06) :381-386
[7]   Prognosis of patients with atherothrombotic disease:: A prospective survey in a non-hospital setting [J].
Ferrieres, Jean ;
Cambou, Jean-Pierre ;
Gayet, Jean-Louis ;
Herrmann, Marie-Annick ;
Leizorovicz, Alain .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 112 (03) :302-307
[8]   EDINBURGH ARTERY STUDY - PREVALENCE OF ASYMPTOMATIC AND SYMPTOMATIC PERIPHERAL ARTERIAL-DISEASE IN THE GENERAL-POPULATION [J].
FOWKES, FGR ;
HOUSLEY, E ;
CAWOOD, EHH ;
MACINTYRE, CCA ;
RUCKLEY, CV ;
PRESCOTT, RJ .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1991, 20 (02) :384-392
[9]   A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) [J].
Gent, M ;
Beaumont, D ;
Blanchard, J ;
Bousser, MG ;
Coffman, J ;
Easton, JD ;
Hampton, JR ;
Harker, LA ;
Janzon, L ;
Kusmierek, JJE ;
Panak, E ;
Roberts, RS ;
Shannon, JS ;
Sicurella, J ;
Tognoni, G ;
Topol, EJ ;
Verstraete, M ;
Warlow, C .
LANCET, 1996, 348 (9038) :1329-1339
[10]   A randomized, controlled trial for risk factor reduction in patients with symptomatic vascular disease: the multidisciplinary Vascular Prevention by Nurses Study (VENUS) [J].
Goessens, Bertine M. B. ;
Visseren, Frank L. J. ;
Sol, Berna G. M. ;
de Man-van Ginkel, Janneke M. ;
van der Graaf, Yolanda .
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2006, 13 (06) :996-1003